Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 42, 2012 - Issue 11
671
Views
40
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Metabolism of ibuprofen in zebrafish larvae

, , , &
Pages 1069-1075 | Received 03 Feb 2012, Accepted 09 Apr 2012, Published online: 17 May 2012
 

Abstract

  1. The application of zebrafish (Danio rerio) larvae to drug discovery assays and toxicity testing, and the occurrence of pharmaceuticals in the environment, has resulted in a need to understand the extent of the metabolic capabilities in the early life stages of this species.

  2. The aims of this study were to determine if zebrafish larvae absorbed, metabolized and excreted the model pharmaceutical, ibuprofen. Zebrafish larvae (72 h post fertilization) were exposed to ibuprofen (100 µg/L), 14C-ibuprofen (100 µg/L) or a solvent control (ethanol) for ≤24 h. Water samples and larval extracts were assessed for metabolites of ibuprofen using liquid chromatography mass spectrometry (LC–MS–MS). Fractions from the separation of the samples treated with 14C-ibuprofen were collected after chromatography and analysed for 14C content by scintillation counting.

  3. Assessment of larval extracts and water samples by LC–MS–MS at 24 h resulted in the identification of hydroxy-ibuprofen in both water samples and larval extracts (8.2 and 0.08% of the total detected 14C, respectively). A second putative hydroxy-ibuprofen moiety was also observed in water samples at trace levels, and a third minor unknown metabolite was detected in larval extracts only by scintillation counting (0.02% of the total 14C detected).

  4. This study provides evidence that zebrafish larvae can metabolize and excrete ibuprofen in a manner known to be cytochrome P450-dependent in mammals, and the similarity to the mammalian pathway supports the use of this system as a surrogate in toxicity and efficacy screening.

Acknowledgements

This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, Award Number BBS/S/N/2006/13057) and AstraZeneca. We thank Peter Jones (The University of Birmingham, UK) for maintenance of the zebrafish, and Rosemary Parslow and Robert Harris (The University of Birmingham, UK) for their advice and assistance with the scintillation counting.

Declaration of interest

The authors reports no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.